Skip to the page

Data / Form D filings / Upstream Metabolics, Inc.

Upstream Metabolics, Inc.: Form D filing

Upstream Metabolics, Inc., a health care company in Lafayette, CA, filed a Form D with the SEC in 2026. The latest, on September 29, 2026, reports $50,000 sold of a $150,000 offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
9 MY RD, Lafayette, CA, 94549
Phone
(925) 330-9809
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2026
Revenue range
No Revenues
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2151718

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 29, 2026New notice$150,000$50,000$100,0001Sep 21, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Sam Harper ThorpeExecutive Officer, Director
Ashley Nicole SmithExecutive Officer, Director

Other health care companies in California that filed recently

Every Form D from the week of Sep 28, 2026 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Upstream Metabolics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.